Insider Selling: Michael Arbige Sells 1,000 Shares of Solazyme Stock (SZYM)
Solazyme (NASDAQ:SZYM) Director Michael Arbige unloaded 1,000 shares of the company’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $10.70, for a total value of $10,700.00. Following the sale, the director now directly owns 132,787 shares in the company. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
A number of analysts have recently weighed in on SZYM shares. Analysts at Robert W. Baird raised their price target on shares of Solazyme (NASDAQ:SZYM) from $12.00 to $16.00 in a research note to investors on Thursday, August 8th. They now have an “outperform” rating on the stock. Separately, analysts at Piper Jaffray Cos. reiterated an “underweight” rating on shares of Solazyme (NASDAQ:SZYM) in a research note to investors on Monday, June 24th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme (NASDAQ:SZYM) in a research note to investors on Monday, June 24th.
One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $13.38.
Solazyme (NASDAQ:SZYM) traded down 1.61% on Monday, hitting $10.41. The stock had a trading volume of 832,760 shares. Solazyme has a one year low of $6.45 and a one year high of $13.09. The stock has a 50-day moving average of $11.51 and a 200-day moving average of $10.34. The company’s market cap is $648.6 million.
Solazyme (NASDAQ:SZYM) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.40) by $0.12. The company had revenue of $11.20 million for the quarter, compared to the consensus estimate of $10.66 million. During the same quarter in the previous year, the company posted ($0.27) earnings per share. The company’s revenue for the quarter was down 17.0% on a year-over-year basis. On average, analysts predict that Solazyme will post $-1.59 earnings per share for the current fiscal year.
Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.